TRANSAVE

Transave, Inc., a biotechnology company, develops inhaled pharmaceuticals for the treatment of lung diseases. The company’s liposomal technology allows the release of drug in the lung's microenvironment. Its products also include Arikace for the treatment of gram-negative lung infections and pseudomonas infections in cystic fibrosis patients; and cisplatin lipid complex for the treatment of cancers affecting the lungs. Transave, Inc. was founded in 1997 and is headquartered in Monmouth Junction, New Jersey. As of December 1, 2010, Transave, Inc. operates as a subsidiary of Insmed Incorporated.

#SimilarOrganizations #People #Financial #More

TRANSAVE

Industry:

Biotechnology Health Care Medical Device

Founded:

1997-01-01

Address:

Monmouth Junction, New Jersey, United States

Country:

United States

Total Employee:

11+

Status:

Active

Total Funding:

58.54 M USD

Similar Organizations

enzyvant-sciences-logo

Enzyvant Sciences

Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.

not_available_image

Ovalis

Ovalis is a biotechnology company that develops catheter-based medical devices for the repair of cardiovascular defects.

Current Advisors List

alex-barkas_image

Alex Barkas Board of Directors @ Transave
Board_member

Current Employees Featured

patrick-mcbrayer_image

Patrick McBrayer
Patrick McBrayer Founder @ Transave
Founder

Founder

patrick-mcbrayer_image

Patrick McBrayer

Investors List

cit-healthcare-finance_image